Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.28 -0.03 (-8.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Net Equity Issued and Repurchased (2011 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Net Equity Issued and Repurchased of $928,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 133.8% from $397,000 a year earlier.

Analysis

Vistagen Therapeutics (VTGN) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Vistagen Therapeutics was $539,000, up 74.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $8,000.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -73.9% (FY2021 to FY2026).
  • In prior fiscal years, Vistagen Therapeutics' Net Equity Issued and Repurchased was $93.45 million in FY2024 and $6.2 million in FY2022 (-6.1%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$30.63 million in fiscal Q4 2026 to a high of $57.21 million in fiscal Q4 2024 over five years.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was fiscal Q1 2024, with growth of 637.9%; the weakest was fiscal Q2 2023, with a decline of 99.9%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior fiscal quarters was -$30.63 million (Q4 2026), $2.31 million (Q3 2026) and $27.93 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - 928,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 928,000.00
Mar 31, 2026 -30.63 Mn
Dec 31, 2025 2.31 Mn
Sep 30, 2025 27.93 Mn
Jun 30, 2025 397,000.00
Mar 31, 2025 -1.06 Mn
Dec 31, 2024 970,000.00
Jun 30, 2024 88,000.00
Mar 31, 2024 57.21 Mn
Dec 31, 2023 210,000.00
Sep 30, 2023 933,000.00
Dec 31, 2022 -160,500.00
Sep 30, 2022 4,400.00
Jun 30, 2022 156,100.00
Mar 31, 2022 -7,400.00
Dec 31, 2021 1.95 Mn
Sep 30, 2021 3.15 Mn
Jun 30, 2021 1.11 Mn
Mar 31, 2021 4.90 Mn
Sep 30, 2020 -2.68 Mn
API Access

Vistagen Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VTGN&period=max&api_key=YOUR_API_KEY